Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06631352
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-10-06
Brief Title:
Outcomes and Prognostic Factors in Hepatopancreatoduodenectomy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Outcomes and Prognostic Factors in Hepatopancreatoduodenectomy
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HPD_single
Brief Summary:
1 In biliary tract malignancies achieving a microscopically clear resection margin R0 is considered the only treatment for a cure
2 HepatopancreatoduodenectomyHPD has been considered a surgical option for patients with extensive bile duct or gallbladder cancer to achieve an R0 resection
3 The associated high morbidity and mortality rates have prevented HPD from becoming a standard surgical procedure worldwide
4 Over the past few decades the understanding of the bile duct anatomy has significantly improved and many methods have been developed to assess liver function and future remnant liver volume
5 We aimed to evaluate the short- and long-term outcomes of HPD and to assess risk factors associated with survival early recurrence and major complications to better evaluate the potential of the procedure as a standard treatment
2 HepatopancreatoduodenectomyHPD has been considered a surgical option for patients with extensive bile duct or gallbladder cancer to achieve an R0 resection
3 The associated high morbidity and mortality rates have prevented HPD from becoming a standard surgical procedure worldwide
4 Over the past few decades the understanding of the bile duct anatomy has significantly improved and many methods have been developed to assess liver function and future remnant liver volume
5 We aimed to evaluate the short- and long-term outcomes of HPD and to assess risk factors associated with survival early recurrence and major complications to better evaluate the potential of the procedure as a standard treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None